10-QPeriod: Q1 FY2004

AFLAC INC Quarterly Report for Q1 Ended Mar 31, 2004

Filed May 6, 2004For Securities:AFL

Summary

Aflac Incorporated's first quarter 2004 report indicates a strong performance, driven by significant growth in both its Japanese and U.S. operations. Total revenues increased to $3.28 billion from $2.81 billion in the prior year's quarter. Net earnings saw a substantial rise to $315 million, or $0.61 per diluted share, compared to $237 million, or $0.45 per diluted share, in Q1 2003. This growth reflects solid premium income increases, particularly in Japan, and improved net investment income. The company continues to emphasize its core supplemental insurance business, with AFLAC Japan being the primary contributor to earnings. AFLAC Japan's pretax operating earnings grew by 22.3% year-over-year, supported by a favorable shift in product mix and sales of its "EVER" medical policy. AFLAC U.S. also demonstrated robust growth, with pretax operating earnings up 14.4% due to increased premium income and effective sales strategies. The company maintains a strong financial position and is focused on enhancing shareholder value through strategic investments and share repurchases.

Key Highlights

  • 1Net earnings increased by 33% to $315 million in Q1 2004, compared to $237 million in Q1 2003.
  • 2Diluted earnings per share rose to $0.61 from $0.45 in the same period.
  • 3Total revenues grew by 17% to $3.28 billion.
  • 4AFLAC Japan's pretax operating earnings increased by 22.3% to $349 million, driven by strong premium income growth and a favorable product mix.
  • 5AFLAC U.S.'s pretax operating earnings rose by 14.4% to $122 million, reflecting solid sales performance.
  • 6The company repurchased approximately 3.15 million shares of common stock during the quarter.
  • 7The company's financial strength ratings remain robust, with "AA" from S&P and Fitch, and "Aa2" from Moody's for financial strength.

Frequently Asked Questions

Aflac reported a strong first quarter in 2004 with net earnings of $315 million, an increase of 33% compared to the prior year's quarter. Diluted earnings per share grew to $0.61 from $0.45, driven by total revenue growth of 17% to $3.28 billion. This performance was supported by strong premium income and investment income from both its Japanese and U.S. operations.

Aflac Japan continued to be the primary earnings contributor, with pretax operating earnings increasing by 22.3% to $349 million, largely due to a favorable product mix and sales growth in its EVER medical policy. Aflac U.S. also showed significant improvement, with pretax operating earnings up 14.4% to $122 million, driven by enhanced sales strategies and increased premium income.

For 2004, Aflac aims to achieve net earnings per diluted share of at least $2.21, representing a 17% increase. The company also targets a 5% to 10% increase in total new annualized premium sales in Japan (in yen) and a 10% to 12% increase in total new annualized premium sales in the U.S.

Aflac's investment strategy focuses on fixed-income securities to generate reliable investment income. The company maintains a high credit quality portfolio, primarily investing in "A" and "AA" rated debt securities. While investment yields have declined compared to the previous year, Aflac continues to manage its portfolio to support policyholder obligations and enhance shareholder equity.